Nils Lindefors, M.D., Ph.D.

Affiliations: 
Psychiatry Karolinska Institute, Stockholm, Sweden 
Google:
"Nils Lindefors"
Mean distance: 14.85 (cluster 6)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Plavén-Sigray P, Hedman E, Victorsson P, et al. (2017) Extrastriatal dopamine D2-receptor availability in social anxiety disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Tiger M, Rück C, Forsberg A, et al. (2014) Reduced 5-HT(1B) receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder. Psychiatry Research. 223: 164-70
Cervenka S, Hedman E, Ikoma Y, et al. (2012) Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder. Translational Psychiatry. 2: e120
Radu D, Tomkinson B, Zachrisson O, et al. (2006) Overlapping regional distribution of CCK and TPPII mRNAs in Cynomolgus monkey brain and correlated levels in human cerebral cortex (BA 10). Brain Research. 1104: 175-82
Radu D, Brodin E, Weber G, et al. (2001) Delayed stress-induced increase in tissue level of cholecystokinin in rat prefrontal cortex: modulation by microdialysis probe implantation and systemic ketamine. Brain Research. 908: 197-203
Zachrisson O, Nomikos GG, Marcus MM, et al. (2000) Effects of antipsychotic drugs on cholecystokinin and preprotachykinin (substance P) mRNA expression in the rat hippocampal formation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 10: 355-63
Radu D, Zachrisson O, de Belleroche J, et al. (2000) Cholecystokinin in CCKB receptor mRNA isoforms: Expression in post-mortem monkey and human brain — alterations following schizophrenia Schizophrenia Research. 41: 254-255
Zachrisson O, de Belleroche J, Wendt KR, et al. (1999) Cholecystokinin CCK(B) receptor mRNA isoforms: expression in schizophrenic brains. Neuroreport. 10: 3265-8
Zachrisson O, Lindefors N, Brené S. (1998) A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity. Brain Research. Molecular Brain Research. 60: 291-5
Falkenberg T, Lindefors N, O'Connor WT, et al. (1997) GABA release and GAD67 mRNA expression in rat hippocampus following entorhinal cortex activation. Brain Research. Molecular Brain Research. 48: 413-6
See more...